Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis. Zettl UK, Rommer P, Hipp P, Patejdl R Ther Adv Neurol Disord. 2016 Jan; 9(1):9-30. PMID: 26788128. Abstract CommentRecommendBookmarkWatch